Anti-Aggregative Therapy and Laser Iridectomy

Sheba Medical Center

Status and phase: Unknown; Phase 4

Conditions: Eyes With Narrow Angle

Treatments: Drug: The cessation of anti-aggregative treatment for 10 days

Study type: Interventional

Funder types: Other

Identifiers

NCT00426400

SHEBA-05-3876-HLV-CTIL

Details and patient eligibility

About

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patients will undergo first laser treatment with the anti-aggregative treatment and will scheduled for next lase in the other eye after discontinuing the anti-aggregative treatment. The patients will be followed-up for 3 months.

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with narrow angle that need laser iridectomy and take anti- aggregative treatment
• over 20 years old
• patients who can stop their anti-aggregative treatment for 10 days

Exclusion criteria

• under coumadin treatment
• post ocular surgeries

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)